{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:58:39Z","timestamp":1787007519735,"version":"build-2736575974"},"reference-count":234,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2017,4,3]]},"DOI":"10.1080\/17474086.2017.1297704","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T11:08:05Z","timestamp":1487675285000},"page":"345-364","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends"],"prefix":"10.1080","volume":"10","author":[{"given":"Maximilian","family":"Stahl","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902908"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-522136"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.07.003"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-015-0269-y"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-337964"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28641"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.06.001"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.2395"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22570"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.5598"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO;2-Q"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)80014-D"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2015.06.004"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-518886"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12246"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400994"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.04.003"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12361"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005143"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170116"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09586"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.01.020"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09132"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.74"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.288"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103283"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10496"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-381665"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.1061936"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2016.1220534"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.02.003"},{"key":"e_1_3_2_35_1","first-page":"2013","article-title":"Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights","volume":"522","author":"Platzbecker U","year":"2013","unstructured":"Platzbecker U. Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights. Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program. 2013;522\u2013528:2013.","journal-title":"Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.8652"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.08.006"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0338"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.48.9146"},{"key":"e_1_3_2_40_1","first-page":"2010","article-title":"Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome","volume":"325","author":"Cutler C","year":"2010","unstructured":"Cutler C. Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome. Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program. 2010;325\u2013329:2010.","journal-title":"Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0104"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-492884"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2013.840997"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061292"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041668"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14610"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-567958"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24173"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.283"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12884"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2011.0006"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-011-0088-6"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004462"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106968"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-013-0172-3"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.3978"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5696"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23454"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.10.013"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.0764"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.08.013"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.7379"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-453555"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-542720"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.044602"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2926"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23697"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26567"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.03.001"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405070"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24173"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00067-8"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013343"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp258"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.02.005"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.3353"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.06.005"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.033506"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.101055"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25036"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21618"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0912-6"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3264"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23303"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2013.814456"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200602"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.49"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2015.11.003"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0067"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.085217"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.336"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-567057"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399337"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377275"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-560227"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-453068"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1061191"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2492"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(09)70005-0"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08749.x"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06546.x"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-S3-35"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01085.x"},{"issue":"4","key":"e_1_3_2_106_1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood.V95.4.1175.004k51_1175_1179","article-title":"Effect of recombinant human erythropoietin combined with granulocyte\/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM\/EPO MDS Study Group","volume":"95","author":"Thompson JA","year":"2000","unstructured":"Thompson JA, Gilliland DG, Prchal JT, et al. Effect of recombinant human erythropoietin combined with granulocyte\/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM\/EPO MDS Study Group. Blood. 2000;95(4):1175\u20131179.","journal-title":"Blood"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2252"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-211797"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1686-4"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06070.x"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-10-1264"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0450-7"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24090"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04153.x"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096370"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07181.x"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08909.x"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.1.68.413k23_68_75"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512442"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.16"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-3-200208060-00007"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.083345"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403239"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7010"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2867"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9214"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.2686"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08145.x"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08979.x"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-068833"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.0118"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-415661"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.296"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.117"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21792"},{"issue":"94","key":"e_1_3_2_136_1","article-title":"Low-dose hypomethylating agents (HMAs) are effective in patients (Pts) with low- or intermediate-1-risk myelodysplastic syndrome (MDS): a report on behalf of the MDS clinical research consortium","volume":"126","author":"Short N","year":"2015","unstructured":"Short N, Garcia-Manero G, Bravo M, et al. Low-dose hypomethylating agents (HMAs) are effective in patients (Pts) with low- or intermediate-1-risk myelodysplastic syndrome (MDS): a report on behalf of the MDS clinical research consortium. Blood. 2015;126:94.","journal-title":"Blood"},{"key":"e_1_3_2_137_1","article-title":"A phase II trial of low-dose hypomethylating agents in patients with low- or intermediate-1-risk MDS","author":"Short N","year":"2016","unstructured":"Short N, Garcia-Manero G, Bravo M, et al. A phase II trial of low-dose hypomethylating agents in patients with low- or intermediate-1-risk MDS. SOHO. 2016.","journal-title":"SOHO"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-434639"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.26"},{"key":"e_1_3_2_140_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.LBA-5.LBA-5","article-title":"A randomized phase II study of azacitidine combined with lenalidomide or with vorinostat Vs. Azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117","volume":"124","author":"Sekeres MA","year":"2014","unstructured":"Sekeres MA, Othus M, List AF, et al. A randomized phase II study of azacitidine combined with lenalidomide or with vorinostat Vs. Azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117. Blood. 2014;124.","journal-title":"Blood"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3102"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.8"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.140988"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-050526"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.02.017"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3325"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404747"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1859-1"},{"key":"e_1_3_2_150_1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood.V116.21.1868.1868","article-title":"Should immunosuppressive THERAPY (IST) be used more often in lower risk MDS?","volume":"116","author":"Cereja S","year":"2010","unstructured":"Cereja S, Brechignac S. L Ades, et al. Should immunosuppressive THERAPY (IST) be used more often in lower risk MDS? Blood. 2010;116:1868.","journal-title":"Blood"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-330126"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811267106"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.08.001"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1863-5"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S50482"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0361"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.1.380"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.10.4914"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.699"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(99)00250-4"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.140"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0012-1"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021162"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4346"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(09)70230-9"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24894"},{"key":"e_1_3_2_168_1","first-page":"2012","article-title":"Novel therapeutic strategies: hypomethylating agents and beyond","volume":"65","author":"Santini V","year":"2012","unstructured":"Santini V. Novel therapeutic strategies: hypomethylating agents and beyond. Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program. 2012;65\u201373:2012.","journal-title":"Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-163246"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4781"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907109106"},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.71"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080630"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24661"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-289280"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30532"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.214"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/5047"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0080"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1146251"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0026-8"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.325"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(07)70461-7"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0007"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0118-z"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.12.004"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(07)70460-5"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.04.006"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21192"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer.15.20"},{"key":"e_1_3_2_191_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21269"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054924"},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00112-X"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-50"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618090"},{"key":"e_1_3_2_196_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.193"},{"key":"e_1_3_2_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00072-5"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-139824"},{"issue":"3","key":"e_1_3_2_199_1","doi-asserted-by":"crossref","first-page":"iii41","DOI":"10.1136\/ard.60.90003.iii41","article-title":"Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines","volume":"60","author":"Greenberg P","year":"2001","unstructured":"Greenberg P. Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Ann Rheum Dis. 2001;60(Suppl 3):iii41\u201342.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13088"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006193"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw013"},{"key":"e_1_3_2_203_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1112635"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-016-0344-z"},{"key":"e_1_3_2_205_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4097"},{"key":"e_1_3_2_206_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.13"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3512"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(15)30015-1"},{"key":"e_1_3_2_209_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V126.23.92.92","article-title":"Luspatercept treatment leads to long term increases in hemoglobin and reductions in transfusion burden in patients with low or intermediate-1 risk myelodysplastic syndromes (MDS): preliminary results from the phase 2 PACE-MDS extension study","volume":"126","author":"Giagounidis A","year":"2015","unstructured":"Giagounidis A, Platzbecker U, Germing U, et al. Luspatercept treatment leads to long term increases in hemoglobin and reductions in transfusion burden in patients with low or intermediate-1 risk myelodysplastic syndromes (MDS): preliminary results from the phase 2 PACE-MDS extension study. Blood. 2015;126:92.","journal-title":"Blood"},{"key":"e_1_3_2_210_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2137"},{"key":"e_1_3_2_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00009-7"},{"issue":"7031","key":"e_1_3_2_212_1","article-title":"Phase II study of orally administered rigosertib (ON 01910.Na) in transfusion-dependent lower-risk myelodysplastic syndrome (MDS) patients","volume":"31","author":"Azra Raza SM","year":"2013","unstructured":"Azra Raza SM, Andrew Eisenberger J, Mears G, et al. Phase II study of orally administered rigosertib (ON 01910.Na) in transfusion-dependent lower-risk myelodysplastic syndrome (MDS) patients. J Clin Oncol. 2013;31:suppl; abstr 7031.","journal-title":"J Clin Oncol"},{"key":"e_1_3_2_213_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.03.005"},{"key":"e_1_3_2_214_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.297"},{"key":"e_1_3_2_215_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28663"},{"key":"e_1_3_2_216_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood.V126.23.91.91","article-title":"Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim results on efficacy, safety and quality of life of an international, multicenter prospective, randomized, trial","volume":"126","author":"Oliva EN","year":"2015","unstructured":"Oliva EN, Santini V, Alati C, et al. Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim results on efficacy, safety and quality of life of an international, multicenter prospective, randomized, trial. Blood. 2015;126:91.","journal-title":"Blood"},{"key":"e_1_3_2_217_1","first-page":"2013","article-title":"Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes","volume":"511","author":"Saunthararajah Y","year":"2013","unstructured":"Saunthararajah Y. Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes. Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program. 2013;511\u2013521:2013.","journal-title":"Hematol \/The Educ Program Am Soc Hematology. Am Soc Hematology. Educ Program"},{"key":"e_1_3_2_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00038-8"},{"key":"e_1_3_2_219_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.4226"},{"key":"e_1_3_2_220_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.265"},{"key":"e_1_3_2_221_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-646398"},{"key":"e_1_3_2_222_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100206"},{"key":"e_1_3_2_223_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.298"},{"key":"e_1_3_2_224_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.211"},{"key":"e_1_3_2_225_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.124"},{"key":"e_1_3_2_226_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.323.323"},{"key":"e_1_3_2_227_1","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood.V126.23.2509.2509","article-title":"Evaluation of the pharmacokinetics of AG-221, a potent mutant IDH2 inhibitor, in patients with IDH2-mutation positive advanced hematologic malignancies in a phase 1\/2 trial","volume":"126","author":"Gao Y","year":"2015","unstructured":"Gao Y, Fan B, Le K, et al. Evaluation of the pharmacokinetics of AG-221, a potent mutant IDH2 inhibitor, in patients with IDH2-mutation positive advanced hematologic malignancies in a phase 1\/2 trial. Blood. 2015;126:2509.","journal-title":"Blood"},{"key":"e_1_3_2_228_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0916-967"},{"key":"e_1_3_2_229_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310523"},{"key":"e_1_3_2_230_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78789"},{"key":"e_1_3_2_231_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2016.1220534"},{"key":"e_1_3_2_232_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_3_2_233_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-567453"},{"key":"e_1_3_2_234_1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V126.23.1666.1666","article-title":"Stabilization of myelodysplastic syndromes (MDS) following hypomethylating agent (HMAs) failure using the immune checkpoint inhibitor ipilimumab: a phase I trial","volume":"126","author":"Zeidan AM","year":"2015","unstructured":"Zeidan AM, Zeidner J, Duffield A, et al. Stabilization of myelodysplastic syndromes (MDS) following hypomethylating agent (HMAs) failure using the immune checkpoint inhibitor ipilimumab: a phase I trial. Blood. 2015;126:1666.","journal-title":"Blood"},{"issue":"1","key":"e_1_3_2_235_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hem.V9.1.1188","article-title":"Surprising splicing: the new most frequent class of genetic alteration in myelodysplastic syndromes","volume":"9","author":"Steensma DP","year":"2012","unstructured":"Steensma DP. Surprising splicing: the new most frequent class of genetic alteration in myelodysplastic syndromes. The Hematologist. 2012;9(1):1.","journal-title":"The Hematologist"},{"key":"e_1_3_2_236_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4165"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2017.1297704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:21:02Z","timestamp":1770888062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2017.1297704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":234,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,3]]}},"alternative-id":["10.1080\/17474086.2017.1297704"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2017.1297704","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}